Tentando aprender a traduzir a partir dos exemplos de tradução humana.
A partir de tradutores profissionais, empresas, páginas da web e repositórios de traduções disponíveis gratuitamente
Εµβολιαζόµενοι µε ανοσοεπάρκεια
immunocompetent vaccinees
Última atualização: 2012-04-11
Frequência de uso: 2
Qualidade:
Οι εµβολιαζόµενοι µε ιστορικό
vaccinees with a history of
Última atualização: 2011-10-23
Frequência de uso: 1
Qualidade:
Aviso: esta concordância pode estar incorreta.
Exclua-a, se este for o caso.
Μόνο σπανίως οι εµβολιαζόµενοι έχουν εµφανίσει συµπτώµατα χρόνιας αρθρίτιδας.
only rarely have vaccine recipients developed chronic joint symptoms.
Última atualização: 2012-04-11
Frequência de uso: 2
Qualidade:
Εµβολιαζόµενοι µε ανοσοανεπάρκεια (π. χ. ασθενείς σε αιµοκάθαρση, µε µεταµόσχευση)
immunocompromised vaccinees (e. g. dialysis patients, transplant patients)
Última atualização: 2012-04-11
Frequência de uso: 2
Qualidade:
Οι εµβολιαζόµενοι µε ιστορικό εµπύρετων σπασµών πρέπει να παρακολουθούνται στενά καθώς τέτοιες ανεπιθύµητες καταστάσεις
vaccinees with a history of febrile convulsions should be closely followed up as such adverse events may occur within 2 to 3 days post vaccination.
Última atualização: 2012-04-11
Frequência de uso: 2
Qualidade:
Οι εµβολιαζόµενοι µε ιστορικό εµπύρετων σπασµών πρέπει να παρακολουθούνται στενά καθώς τέτοιες ανεπιθύµητες καταστάσεις µπορεί να συµβούν εντός 2 έως 3 ηµερών µετά τον εµβολιασµό.
vaccinees with a history of febrile convulsions should be closely followed up as such adverse events may occur within 2 to 3 days post vaccination.
Última atualização: 2017-04-26
Frequência de uso: 1
Qualidade:
Αν και είναι άγνωστη η διάρκεια του προστατευτικού αποτελέσµατος µίας προηγούµενης σύνθεσης ανασυνδυασµένου εµβολίου ηπατίτιδας Β της merck σε υγιείς εµβολιαζόµενους, η παρακολούθηση επί 5- 9 έτη 3, 000 περίπου ατόµων υψηλού κινδύνου, που τους χορηγήθηκε παρόµοιο εµβόλιο παραγόµενο από πλάσµα, δεν απεκάλυψε περιστατικά κλινικά έκδηλης λοίµωξης από ηπατίτιδα Β.
although the duration of the protective effect of a previous formulation of merck’ s recombinant hepatitis b vaccine in healthy vaccinees is unknown, follow-up over 5-9 years of approximately 3,000 high-risk subjects given a similar plasma-derived vaccine has revealed no cases of clinically apparent hepatitis b infection.
Última atualização: 2012-04-11
Frequência de uso: 6
Qualidade: